Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Final Data for Pancreatic

View:

Post by JohnnyYeg on Apr 29, 2021 5:40pm

Final Data for Pancreatic

So the final data for the NU 18I01 "Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer" is being presented at ASCO in June. Not a simple press release - but a presentation at ASCO. Interesting. Something compelling to present? https://www.clinicaltrials.gov/ct2/show/NCT03723915?term=Pelareorep%3B+reolysin&draw=2&rank=1

419

Comment

Comment by fox7mf on Apr 29, 2021 5:53pm

I believe they are presenting this data from the ph2 clinical trials with Merck a little earlier than anticipated. Hopefully due to very compelling results.

216

Comment